{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:25:07Z","timestamp":1779110707163,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100013568","name":"Aneurysm and AVM Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013568","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s12028-021-01285-2","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T16:02:36Z","timestamp":1626796956000},"page":"202-207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Isofurans and Isoprostanes as Potential Markers of Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage: A Prospective Observational Study"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5550-2177","authenticated-orcid":false,"given":"Joao A.","family":"Gomes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ginger","family":"Milne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asha","family":"Kallianpur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Shriver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"key":"1285_CR1","doi-asserted-by":"crossref","unstructured":"Hanggi D, Participants in the International Multi-Disciplinary Consensus Conference on the Critical Care Management of Subarachnoid H. Monitoring and detection of vasospasm II: EEG and invasive monitoring. Neurocrit Care 2011;15(2):318\u201323.","DOI":"10.1007\/s12028-011-9583-y"},{"issue":"5","key":"1285_CR2","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3171\/2015.4.JNS15428","volume":"124","author":"G Kumar","year":"2016","unstructured":"Kumar G, Shahripour RB. Harrigan MR (2016) Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurosurg. 2016;124(5):1257\u201364.","journal-title":"J Neurosurg"},{"key":"1285_CR3","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s10143-018-1037-y","volume":"43","author":"R Jabbarli","year":"2020","unstructured":"Jabbarli R, Pierscianek D, Darkwah Oppong M, et al. Laboratory biomarkers of delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review. Neurosurg Rev. 2020;43:825\u201333.","journal-title":"Neurosurg Rev"},{"key":"1285_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1750-3639.2005.tb00511.x","volume":"15","author":"LJ Roberts","year":"2005","unstructured":"Roberts LJ, Fessel JP, Davies SS. The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Brain Pathol. 2005;15:143\u20138.","journal-title":"Brain Pathol"},{"key":"1285_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.wneu.2017.07.145","volume":"107","author":"K Wisniewski","year":"2017","unstructured":"Wisniewski K, Bienkowski M, Tomasik B, et al. Urinary F2-isoprostane concentration as a poor prognostic factor after subarachnoid hemorrhage. World Neurosurg. 2017;107:185\u201393.","journal-title":"World Neurosurg"},{"issue":"8","key":"1285_CR6","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.freeradbiomed.2005.12.019","volume":"40","author":"C-L Lin","year":"2006","unstructured":"Lin C-L, Hsu Y-T, Lin T-K, et al. Increased levels of F2-isoprostanes following aneurysmal subarachnoid hemorrhage in humans. Free Radic Biol Med. 2006;40(8):1466\u201373.","journal-title":"Free Radic Biol Med"},{"key":"1285_CR7","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1089\/ars.2011.4125","volume":"15","author":"TB Corcoran","year":"2011","unstructured":"Corcoran TB, Mas E, Barden AE, et al. Are isofurans and neuroprostanes increased after subarachnoid hemorrhage and traumatic brain injury? Antioxid Redox Signal. 2011;15:2663\u20137.","journal-title":"Antioxid Redox Signal"},{"key":"1285_CR8","doi-asserted-by":"publisher","first-page":"F423","DOI":"10.1152\/ajprenal.00321.2017","volume":"314","author":"DL Kirkman","year":"2018","unstructured":"Kirkman DL, Muth BJ, Ramick MG, et al. Role of mitochondria-derived reactive oxygen species in microvascular dysfunction in chronic kidney disease. Am J Physiol Renal Physiol. 2018;314:F423\u20139.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"9","key":"1285_CR9","doi-asserted-by":"publisher","first-page":"e12780","DOI":"10.14814\/phy2.12780","volume":"4","author":"JL Gamboa","year":"2016","unstructured":"Gamboa JL, Billings FT, Bojanowski MT, et al. Mitochondrial dysfunction and oxidative stress in patients with chronic kidney disease. Physiol Rep. 2016;4(9):e12780.","journal-title":"Physiol Rep"},{"issue":"3","key":"1285_CR10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1046\/j.1471-4159.2003.01709.x","volume":"85","author":"JP Fessel","year":"2003","unstructured":"Fessel JP, Hulette C, Powell S, Roberts LJ 2nd, Zhang J. Isofurans, but not F2-isoprostanes, are increased in the substantia nigra of patients with Parkinson\u2019s disease and with dementia with Lewy body disease. J Neurochem. 2003 May;85(3):645\u201350.","journal-title":"J Neurochem"},{"issue":"2","key":"1285_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12028-014-9977-8","volume":"21","author":"JA Gomes","year":"2014","unstructured":"Gomes JA, et al. Brain iron metabolism and brain injury following subarachnoid hemorrhage: iCeFISH-pilot (CSF iron in SAH). Neurocrit Care. 2014;21(2):285\u201393.","journal-title":"Neurocrit Care"},{"key":"1285_CR12","doi-asserted-by":"crossref","unstructured":"Bruno A, Akinwuntan AE, Lin Chen, Close B et al. Simplified Modified Rankin Scale Questionnaire. Reproducibility over the telephone and validation with quality of life. Stroke 2011;42:2276\u201379.","DOI":"10.1161\/STROKEAHA.111.613273"},{"key":"1285_CR13","doi-asserted-by":"crossref","unstructured":"Sander Connolly E, Rabinstein AA, Carhuapoma JR et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage. A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke 2012;43:1711\u201337.","DOI":"10.1161\/STR.0b013e3182587839"},{"key":"1285_CR14","doi-asserted-by":"crossref","unstructured":"Vergouwen, MDI; Participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Vasospasm versus delayed cerebral ischemia as an outcome event in clinical trials and observational studies. Neurocrit Care. 2011;15:308\u201311.","DOI":"10.1007\/s12028-011-9586-8"},{"key":"1285_CR15","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","volume":"73","author":"CE Teunissen","year":"2009","unstructured":"Teunissen CE, Petzold A, Bennett JL, et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology. 2009;73:1914\u201322.","journal-title":"Neurology"},{"key":"1285_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2012.09.030","volume":"59","author":"GL Milne","year":"2013","unstructured":"Milne GL, Gao B, Terry ES, et al. Measurement of F2- isoprostanes and isofurans using gas chromatography\u2013mass spectrometry. Free Radic Biol Med. 2013;59:36\u201344.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"1285_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s12028-019-00710-x","volume":"31","author":"JR Geraghty","year":"2019","unstructured":"Geraghty JR, Davis JL, Testai FD. Neuroinflammation and microvascular dysfunction after experimental subarachnoid hemorrhage: emerging components of early brain injury related to outcome. Neurocrit Care. 2019;31(2):373\u201389.","journal-title":"Neurocrit Care"},{"key":"1285_CR18","doi-asserted-by":"publisher","first-page":"5973","DOI":"10.1021\/cr200160h","volume":"111","author":"GL Milne","year":"2011","unstructured":"Milne GL, Yin H, Hardy KD, et al. Isoprostane generation and function. Chem Rev. 2011;111:5973\u201396.","journal-title":"Chem Rev"},{"key":"1285_CR19","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/jcbfm.2010.137","volume":"30","author":"JY Lee","year":"2010","unstructured":"Lee JY, Keep RF, He Y, et al. Hemoglobin and iron handling in brain after subarachnoid hemorrhage and the effect of deferoxamine on early brain injury. J Cereb Blood Flow Metab. 2010;30:1793\u2013803.","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-021-01285-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-021-01285-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-021-01285-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T11:22:12Z","timestamp":1643887332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-021-01285-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,20]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1285"],"URL":"https:\/\/doi.org\/10.1007\/s12028-021-01285-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.03.10.21252935","asserted-by":"object"}]},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,20]]},"assertion":[{"value":"2 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"We conducted this clinical-translational work adhering to all local legal and ethical guidelines. All participants provided informed consent (or their respective next of kin\/legal representatives), and insitutional review board (IRB) approval was obtained prior to the initiation of the study. All patients were enrolled in the Cleveland Clinic, whereas CSF samples were analyzed at the University of Vanderbilt. A materials and data transfer agreement between both institutions was secured before any samples were transferred.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval\/informed consent"}}]}}